Background {#Sec1}
==========

The World Health Organization (WHO) recommends phasing-in Light Emitting Diode Fluorescent Microscopy (LED-FM) as an alternative to conventional Ziehl-Neelsen microscopy (ZN) for diagnosis of smear-positive pulmonary tuberculosis (TB) \[[@CR1]\]. Many studies in controlled laboratory settings have shown that LED-FM is about 10 % more sensitive and as specific as ZN in detecting TB bacillus on smear microscopy \[[@CR2]\]. In India, since July 2012 under the Revised National Tuberculosis Control Programme, the sputum smear examination for TB bacilli at designated microscopy centers (DMCs) in 200 medical colleges, changed from ZN method to auramine based LED-FM method. LED-FM has been shown to increase the detection of smear positive tuberculosis under routine programmatic conditions \[[@CR3]\].

Unlike at the time of diagnosis, TB patients who undergo follow-up sputum smear examination during TB treatment, produce less sputum and are mostly pauci-bacillary \[[@CR4]\]. There is no evidence from India if use of LED-FM increases the detection of smear positives among patients undergoing follow-up sputum smear examination under routine programmatic conditions. In this study, we evaluated whether implementation of LED-FM increased the yield of smear positives during follow-up and discuss its programmatic implications.

Methodology {#Sec2}
===========

We conducted a before and after comparison study in eight conveniently selected medical colleges in North India that were implementing LED-FM services. The study sample included all TB patients who underwent follow-up sputum smear examination in these colleges during the period July--December 2012 (using LED-FM) and July--December 2011 (using ZN microscopy). TB patients, as a part of monitoring their response to treatment, undergo follow-up smear examination at the end of intensive phase, 2 months into continuation phase and at the end of treatment. Those found to be sputum smear positive are evaluated for drug resistance. Patient details, reasons for sputum smear examination (whether for diagnosis or for follow-up) and results are recorded in the TB laboratory register. For this study, we included all patients who under-went follow-up sputum smear examination conducted during the two study periods. We reviewed the TB laboratory registers and abstracted aggregate data on number of TB patients examined for follow-up and their smear microscopy results including grades.

LED-FM and ZN procedures were performed by trained laboratory technicians. As per programme guidelines, smears were prepared from direct sputum specimens in both techniques. Briefly, for LED-FM, the heat fixed smears were flooded with 0.1 % auramine phenol for 7--10 min, rinsed with running water, decolorized with 3 % acid alcohol for 2 min twice, rinsed with running water, counter stained with 0.1 % potassium permanganate for 30 s, rinsed with running water and air dried \[[@CR4]\]. For ZN microscopy, the heat fixed smears were flooded with 1 % carbol fuchsin for 5 min, rinsed gently with running water, decolorized with 25 % sulphuric acid for 2--4 min, rinsed with water, counter stained with 0.1 % methylene blue for 30 s, rinsed with running water and air dried \[[@CR5]\]. Trained laboratory technicians prepared and examined the smears and reported the results as shown in Table [1](#Tab1){ref-type="table"} \[[@CR3]\]. The microscopy centers performed smear microscopy procedures under a system of external quality assurance which included onsite visits by dedicated laboratory supervisors and periodic, random blinded rechecking of smears \[[@CR6], [@CR7]\]. As per national guidelines, two smears are required to be examined for follow up examinations \[[@CR6]\]. Patient will be labelled as smear positive at follow-up if at least one smear is positive irrespective of the grades. If both smears are positive, the higher microscopy grade is used for reporting. As per the newer national guidelines on programmatic management of drug resistant TB, all TB patients who are smear positive during follow-up at the end of 2 months of intensive phase and/or 5 months of continuous phase (depending upon the districts) are considered as 'presumptive multidrug resistant (MDR)-TB patients' and are investigated for Rifampicin and Isoniazid resistance using culture and drug susceptibility test (CDST) \[[@CR8]\]. If patients are confirmed to be having strains that are resistant to Rifampicin in vitro, they are treated using WHO-recommended standardized second line regimen.Table 1Guidelines of reporting sputum smear microscopy adopted by National Tuberculosis Control Programme in IndiaIUATLD/WHO scale (1000 × field = HPF\*) GradesZiehl Neelsen (ZN) microscopy (1000 × magnification: 1 length = 2 cm = 100 HPF)LED-Fluorescence microscopy (400 × magnification: 1 length = 40 fields = 200 HPF)NegativeZero AFB/1 lengthZero AFB/1 lengthPositiveScanty1--9 AFB/1 length or 100 HPF1--19 AFB/1 length or 100 HPF1+ grade10--99 AFB/1 length or 100 HPF20--199 AFB/1 length2+ grade1--10 AFB/1 HPF on average5--50 AFB/1 HPF on average3+ grade\>10 AFB/1 HPF on average\>50 AFB/1 HPF on average\* *HPF* high power field

The number of TB patients examined during follow-up and proportion found smear positive was computed, separately for LED-FM and ZN microscopy. Chi squared test was used to test statistical significance (p-value ≤0.05) (SPSS v16). Ethics approval for this study was obtained from the Ethics Advisory Group of International Union Against Tuberculosis and Lung Disease (The Union).

Results {#Sec3}
=======

Of 2868 TB patients examined by LED-FM during follow-up, 213 (7.4 %) were smear-positive and of 2740 examined by ZN, 136 (5.0 %) were smear-positive---an additional yield of 77 follow-up smear-positives. The disaggregated results of first and second specimens are shown in Table [2](#Tab2){ref-type="table"}. The additional yield of second specimen (negative on first specimen and positive only on second specimen) was 12.5 % with ZN microscopy whereas it was 21.6 % with LED-FM (p = 0.3).Table 2Performance of LED-FM (July--December 2012) in comparison to ZN microscopy (July--December 2011) in detecting AFB during follow-up of TB patients in eight medical colleges of IndiaTechniqueNumber examinedNumber smear positivePPPNNPProportion smear positive^\#^Additional Yield of second specimen (NP/all positives)\^ZN27401361109175.0 %12.5 %LED-FM286821314918467.4 %21.6 %Absolute increase (relative increase)+128 (4.7 %)+77 (56.6 %)+2.4 % (48 %)*ZN* Ziehl Neelsen Microscopy, *LED-FM* light emitting diode fluorescence microscopy, *AFB* acid fast bacilli, *PP* first and second smear positive, *PN* first smear positive and second smear negative, *NP* first smear negative and second smear positive^\#^p value \< 0.001\^ p value = 0.03

Compared to the before period, in the after-period there was a 5 % increase in the number of TB patients who underwent follow-up sputum smear examination. However, the number of TB patients found to be sputum smear positive rose by more than 50 % (Table [2](#Tab2){ref-type="table"}). Applying 5.0 % positivity (observed in 2011) for the additional number of patients examined in 2012, LED-FM services still resulted in an additional yield of 71 follow-up smear-positives. Most of the increase was noted in smears graded scanty followed by 3+ (p-value \< 0.05) (Table [3](#Tab3){ref-type="table"}). The direct yield was higher by LED-FM in most (n = 7) sites compared.Table 3Comparison between Ziehl Neelson (ZN) and Light Emitting Diode-Fluorescence Microscopic technique (LED-FM) in detecting AFB (by smear quantification) during follow-up of TB patients in eight medical colleges of IndiaSmear grade of patientZN Microscopy 2011LED-FM 2012Change in percentage (95 % CI)p-valuen1%n2%Negative260495.0265592.6−2.4 (−1.1 to −3.7)\<0.0001PositiveScanty331.2752.61.4 (0.7--2.0)0.00011+572.1782.70.6 (−0.1 to 1.4)0.142+291.1270.9−0. 2 (−0. 7 to 0. 4)0.453+170.6331.10.5 (0.0 to 1.0)0.01Total2740100.02868100.0----*ZN* Ziehl Neelsen Microscopy, *LED-FM* light emitting diode fluorescence microscopy, *AFB* acid fast bacilli

Discussion {#Sec4}
==========

This is the first study from India examining the impact of LED-FM on the sputum-positivity during follow-up of TB patients under routine programmatic settings. The increase in yield by LED-FM could be due to (1) increased absorbability of mycolic acid and damaged bacilli to auramine than fuschin, (2) the LED-FM stained background of slide is brighter, making it easier for laboratory technicians to focus and examine slides with fewer bacilli and (3) increased area of the slide examined \[[@CR7], [@CR9]\]. Since these findings come from a setting of quality-assured smear microscopy under routine programmatic settings, they are most likely to be accurate and reflect operational realities and importantly during the period of study external quality assurance did not yield any major errors.

These results have important programme implications. LED-FM leads to an increase in the number of TB patients who will be identified as "presumptive MDR-TB patients" who will require CDST with consequent increase in laboratory workload. Several studies in the past have shown that nearly two-thirds of the smear positives during follow-up were culture negative, especially so if the smears are graded scanty, which most likely represent dead, non-viable bacilli, yet to be excreted out of the body \[[@CR10], [@CR11]\]. Hence, it is not clear if increase in identification of follow-up smear-positives using LED-FM is actually beneficial in enhancing detection of MDR-TB cases or just unnecessary additional workload for the CDST laboratories. Since we do not have information on culture results in our study, the possibility of false positive results could not be assessed and should be a topic for future studies. To avoid this 'smear-positive culture-negative' phenomenon and increase the specificity of smear microscopy during follow-up, The Union in their TB guidelines recommend that all follow-up smear-positives (especially that done during month 5) in the first sample be reconfirmed by a second positive smear using an early morning sputum sample before declaring as 'treatment failure' and start next steps including investigation for MDR-TB \[[@CR11]\]. A recent study from Chennai showed that if only one of the two smears was positive, this is most likely to be scanty and hence culture negative \[[@CR12]\]. Adopting the Union's approach would mean that TB patients who are positive on both the smears only would be investigated for MDR-TB and would thus reduce unnecessary workload. The other alternatives to reduce unnecessary cultures are to use new methods like vital staining with fluorescein diacetate or slide culture, but these are not widely available or validated under routine conditions \[[@CR13]--[@CR15]\].

There were a few limitations to this study. It would have been better if the same samples were processed with the two methods. However, this could not be performed as the ZN microscopy system was already replaced with the LED-FM microscopy in the study sites. The culture and DST results were unavailable and hence it could not be found out if use of LED-FM actually increased the detection of MDR-TB cases. As in all pre-post designs, it is difficult to attribute the entire change to the intervention (LED-FM) as there could be other undocumented changes (for example, pre-treatment smear positivity) during the study period. While we do not suspect this, we have no data to rule it out completely and is one of the limitations. Also the study did not disaggregate the follow-up smears at end of intensive phase and end of treatment. Since the study was conducted in conveniently selected medical colleges, there may be difficulties in generalizing the results to whole of India. Further studies should collect data countrywide or from a representative sample to confirm these results and act upon them.

Conclusions {#Sec5}
===========

Implementation of LED-FM led to increase in identification of follow-up smear-positives among TB patients, mostly graded scanty. This has important resource implications for the TB programme in India.
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